Veroudering, invasieve therapie en de uitkomsten Ageing geriatric screening
Conditions
Interventions
None listed
Sponsors
Leids Universitair Medisch Centrum
Eligibility
Age
65 Years to 99 Years
Inclusion criteria
Inclusion criteria: 1. Aged 70 years or older at day of presentation or younger than 70 with indication for frailty 2. Indication intention to treat for: - Malign process in which a treatment (operation, chemotherapy or radiotherapy) is considered - Vascular disease in which a treatment (operation) is considered - Benign processes in which a treatment (operation, chemotherapy or radiotherapy) is considered - Referral to the outpatient department of gerontology and geriatrics for (neuropsychological) screening or any other reason, subjects older than 70 years could also be included when they are considered vulnerable
Exclusion criteria
Exclusion criteria: 1. Participant not willing to provide informed consent 2. Participant not able to provide informed consent and no proxy available
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main study end points are: The following data will be collected from the medical record after the treatment of the patient is finished: i) duration of admittance ii) days on intensive care or medium care iii) clinical diagnosis of delirium during hospitalization iv) complications during admittance (infections, falls) v) unplanned hospital admittance After a Follow-up of 6 and 12 months after procedure we will collect the following data by a telephone call: i) Mortality will be followed through the registry of the municipality (in Dutch: Gemeentelijke Basis Administratie). ii) Functional decline by Katz-ADL iii) Quality of life will be assessed using EuroQOL-5D. iv) Living arrangement (independent, institutionalized, hospitalized) and level of support (number of days home-care) | — |
Countries
Netherlands
Outcome results
None listed